55PTryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome
Annals of Oncology(2019)
摘要
Background: Indoleamine 2,3 dioxygenase (IDO) catalyzes the conversion of tryptophan (Trp) into kynurenine (Kyn), an immunosuppressive metabolite involved in T regulatory cell differentiation. IDO is expressed in many cancer types, including breast cancer (BC), but its association with prognosis is controversial. Here we analyze Kyn/Trp ratio, known as a surrogate indicator of IDO activity, in BC patients and in healthy control (CTRL).
更多查看译文
关键词
Tryptophan Metabolism
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要